Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1948 1
1949 4
1951 2
1953 1
1954 2
1956 3
1957 1
1958 2
1964 1
1965 1
1966 5
1967 1
1968 4
1969 8
1970 3
1971 6
1972 7
1973 5
1974 4
1975 11
1976 5
1977 9
1978 9
1979 15
1980 16
1981 11
1982 19
1983 14
1984 13
1985 19
1986 20
1987 21
1988 19
1989 19
1990 18
1991 28
1992 27
1993 37
1994 21
1995 36
1996 23
1997 43
1998 26
1999 29
2000 49
2001 60
2002 39
2003 41
2004 55
2005 46
2006 68
2007 57
2008 61
2009 73
2010 77
2011 82
2012 97
2013 81
2014 77
2015 79
2016 67
2017 69
2018 61
2019 76
2020 94
2021 103
2022 90
2023 63
2024 30

Text availability

Article attribute

Article type

Publication date

Search Results

2,083 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Paragangliomas 5"
Page 1
Paraganglioma of the Head and Neck: A Review.
Sandow L, Thawani R, Kim MS, Heinrich MC. Sandow L, et al. Endocr Pract. 2023 Feb;29(2):141-147. doi: 10.1016/j.eprac.2022.10.002. Epub 2022 Oct 15. Endocr Pract. 2023. PMID: 36252779 Free PMC article. Review.
OBJECTIVE: To review the epidemiology, presentation, diagnosis, and management of head and neck paragangliomas. METHODS: A literature review of english language papers with focus on most current literature. RESULTS: Paragangliomas (PGLs) are a group of neuroendocrin …
OBJECTIVE: To review the epidemiology, presentation, diagnosis, and management of head and neck paragangliomas. METHODS: A literature …
Metastatic Pheochromocytomas and Abdominal Paragangliomas.
Granberg D, Juhlin CC, Falhammar H. Granberg D, et al. J Clin Endocrinol Metab. 2021 Apr 23;106(5):e1937-e1952. doi: 10.1210/clinem/dgaa982. J Clin Endocrinol Metab. 2021. PMID: 33462603 Free PMC article. Review.
CONTEXT: Pheochromocytomas and paragangliomas (PPGLs) are believed to harbor malignant potential; about 10% to 15% of pheochromocytomas and up to 50% of abdominal paragangliomas will exhibit metastatic behavior. EVIDENCE ACQUISITION: Extensive searches in the PubMed …
CONTEXT: Pheochromocytomas and paragangliomas (PPGLs) are believed to harbor malignant potential; about 10% to 15% of pheochromocytom …
Multidisciplinary practice guidelines for the diagnosis, genetic counseling and treatment of pheochromocytomas and paragangliomas.
Garcia-Carbonero R, Matute Teresa F, Mercader-Cidoncha E, Mitjavila-Casanovas M, Robledo M, Tena I, Alvarez-Escola C, Arístegui M, Bella-Cueto MR, Ferrer-Albiach C, Hanzu FA. Garcia-Carbonero R, et al. Clin Transl Oncol. 2021 Oct;23(10):1995-2019. doi: 10.1007/s12094-021-02622-9. Epub 2021 May 6. Clin Transl Oncol. 2021. PMID: 33959901 Free PMC article.
Pheochromocytomas and paragangliomas (PPGLs) are rare neuroendocrine tumors that arise from chromaffin cells of the adrenal medulla and the sympathetic/parasympathetic neural ganglia, respectively. ...
Pheochromocytomas and paragangliomas (PPGLs) are rare neuroendocrine tumors that arise from chromaffin cells of the adrenal medulla a …
Biochemical Assessment of Pheochromocytoma and Paraganglioma.
Eisenhofer G, Pamporaki C, Lenders JWM. Eisenhofer G, et al. Endocr Rev. 2023 Sep 15;44(5):862-909. doi: 10.1210/endrev/bnad011. Endocr Rev. 2023. PMID: 36996131
Pheochromocytoma and paraganglioma (PPGL) require prompt consideration and efficient diagnosis and treatment to minimize associated morbidity and mortality. ...Additional measurements of plasma methoxytyramine can be important for some tumors, such as paragangliomas …
Pheochromocytoma and paraganglioma (PPGL) require prompt consideration and efficient diagnosis and treatment to minimize associated m …
Clinical consensus guideline on the management of phaeochromocytoma and paraganglioma in patients harbouring germline SDHD pathogenic variants.
Taïeb D, Wanna GB, Ahmad M, Lussey-Lepoutre C, Perrier ND, Nölting S, Amar L, Timmers HJLM, Schwam ZG, Estrera AL, Lim M, Pollom EL, Vitzthum L, Bourdeau I, Casey RT, Castinetti F, Clifton-Bligh R, Corssmit EPM, de Krijger RR, Del Rivero J, Eisenhofer G, Ghayee HK, Gimenez-Roqueplo AP, Grossman A, Imperiale A, Jansen JC, Jha A, Kerstens MN, Kunst HPM, Liu JK, Maher ER, Marchioni D, Mercado-Asis LB, Mete O, Naruse M, Nilubol N, Pandit-Taskar N, Sebag F, Tanabe A, Widimsky J, Meuter L, Lenders JWM, Pacak K. Taïeb D, et al. Lancet Diabetes Endocrinol. 2023 May;11(5):345-361. doi: 10.1016/S2213-8587(23)00038-4. Epub 2023 Mar 31. Lancet Diabetes Endocrinol. 2023. PMID: 37011647 Free PMC article. Review.
Patients with germline SDHD pathogenic variants (encoding succinate dehydrogenase subunit D; ie, paraganglioma 1 syndrome) are predominantly affected by head and neck paragangliomas, which, in almost 20% of patients, might coexist with paragangliomas arising …
Patients with germline SDHD pathogenic variants (encoding succinate dehydrogenase subunit D; ie, paraganglioma 1 syndrome) are predom …
Pathological grading for predicting metastasis in phaeochromocytoma and paraganglioma.
Kimura N, Takayanagi R, Takizawa N, Itagaki E, Katabami T, Kakoi N, Rakugi H, Ikeda Y, Tanabe A, Nigawara T, Ito S, Kimura I, Naruse M; Phaeochromocytoma Study Group in Japan. Kimura N, et al. Endocr Relat Cancer. 2014 May 6;21(3):405-14. doi: 10.1530/ERC-13-0494. Print 2014 Jun. Endocr Relat Cancer. 2014. PMID: 24521857
GAPP scores of the non-metastatic and metastatic groups were 2.080.17 and 5.330.43 (means.e.m., P<0.001) respectively. There was a significant negative correlation between the GAPP score and the interval until metastasis (r=-0.438, P<0.01). The mean number of years u …
GAPP scores of the non-metastatic and metastatic groups were 2.080.17 and 5.330.43 (means.e.m., P<0.001) respectively. There was a …
Predicting Metastatic Potential in Pheochromocytoma and Paraganglioma: A Comparison of PASS and GAPP Scoring Systems.
Wachtel H, Hutchens T, Baraban E, Schwartz LE, Montone K, Baloch Z, LiVolsi V, Krumeich L, Fraker DL, Nathanson KL, Cohen DL, Fishbein L. Wachtel H, et al. J Clin Endocrinol Metab. 2020 Dec 1;105(12):e4661-70. doi: 10.1210/clinem/dgaa608. J Clin Endocrinol Metab. 2020. PMID: 32877928 Free PMC article.
PURPOSE: The Pheochromocytoma of the Adrenal Gland Scaled Score (PASS) and the Grading System for Adrenal Pheochromocytoma and Paraganglioma (GAPP) are scoring systems to predict metastatic potential in pheochromocytomas (PCC) and paragangliomas (PGLs). ...RESULTS: …
PURPOSE: The Pheochromocytoma of the Adrenal Gland Scaled Score (PASS) and the Grading System for Adrenal Pheochromocytoma and Paragangli …
Sporadic paraganglioma.
Lee JA, Duh QY. Lee JA, et al. World J Surg. 2008 May;32(5):683-7. doi: 10.1007/s00268-007-9360-4. World J Surg. 2008. PMID: 18224469 Review.
Paraganglioma are rare chromaffin cell tumors that develop from the neural crest cells. ...Many are malignant. Medical management of catecholamine-secreting paraganglioma is the same as for pheochromocytoma. Favorably located abdominal paragangliomas can be s …
Paraganglioma are rare chromaffin cell tumors that develop from the neural crest cells. ...Many are malignant. Medical management of …
Bilateral paraganglioma.
Trivedi RY, Leong SC. Trivedi RY, et al. BMJ Case Rep. 2012 Nov 9;2012:bcr0120125639. doi: 10.1136/bcr-01-2012-5639. BMJ Case Rep. 2012. PMID: 23144338 Free PMC article.
There was a similar enhancing lesion on the right side, measuring 2.6 cm2 cm at the level of the carotid bifurcation and 5&emsp14;cm 2.6&emsp14;cm at the jugular bulb, this is seen in figure 1. A diagnosis of bilateral paraganglioma was …
There was a similar enhancing lesion on the right side, measuring 2.6 cm2 cm at the level of the carotid bifurcation a …
Vagal paragangliomas.
Sniezek JC, Netterville JL, Sabri AN. Sniezek JC, et al. Otolaryngol Clin North Am. 2001 Oct;34(5):925-39, vi. doi: 10.1016/s0030-6665(05)70355-8. Otolaryngol Clin North Am. 2001. PMID: 11557447 Review.
The management of vagal paragangliomas is extremely challenging. Treatment of these lesions must be tailored individually for each patient. ...This article discusses clinical presentation, multicentric and malignant vagal paragangliomas, evaluation, embolization, su …
The management of vagal paragangliomas is extremely challenging. Treatment of these lesions must be tailored individually for each pa …
2,083 results